Nuvelo (Nasdaq: NUVO) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Nuvelo (Nasdaq: NUVO)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: steve kammerer who wrote (258)	2/6/2003 8:28:30 PM
From: SemiBull	Read Replies (1) of 286

I thought HYSQ took over VGNX but the article you posted talks about merger. The term merger can be misused on occasion unless two companies throw all (or some) of their assets into a new pot and actually "merge." Acquisitions are sometimes referred to as mergers for some unsound reason. The board, excluding CEO and Chair, will have 2 members from HYSQ and 3 from VGNX. I think the following quote should clear up any confusion: As previously announced, Dr. Ted W. Love will serve as president, CEO and board member of Nuvelo and Dr. George Rathmann will assume the chairmanship of the new board. The remainder of the Nuvelo board of directors will include Richard Brewer and Mary Pendergast from the Hyseq board and Dr. Philippe Chambon, Dr. Jean-Francois Formela and Martin Vogelbaum from the VARIAGENICS board. biz.yahoo.com (I count 4 from HYSQ and 3 from VGNX, with the Chairman slot going to HYSQ's Rathmann.) Basically what company do I own shares in? You account should reflect the same number of shares in NUVO as you previously owned in HYSQ.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next